Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07521241

A Clinical Trial to Evaluate the Pharmacokinetics and Safety of AD-230 in Healthy Adults

A Clinical Trial to Evaluate the Pharmacokinetics and Safety of AD-230 in Healthy Adults

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Chronic Liver Disease (CLD)

Age range

19 year–64 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 1

Primary location

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • - Body mass index (BMI) between 18.5 kg/m2 and 29.9 kg/m2 at the time of screening visit
  • Subjects aged 19 years or older and under 65 years at the screening visit

Exclusion criteria

  • Participation in another clinical study with an investigational drug within the 6 months from scheduled first administration
  • Other exclusions applied

Treatment and study plan

AD-230, AD-2301

Drug

Oral administration of AD-230 or AD-2301, according to randomized sequence.

Primary outcomes

  1. AUClast

    Time frame: -24hours to 72hours

  2. Cmax

    Time frame: -24hours to 72hours

Study contacts

Contact information is provided by the study sponsor or research team.

Sarah Yoon

CONTACT

[email protected]

031-891-5576

Sponsors and collaborators

Lead sponsor

Addpharma Inc.

Industry

Registry information

Official study title

A Randomized, Open-label, Two-treatment, Two-period, Two-sequence Crossover Clinical Trial to Evaluate the Pharmacokinetics and Safety of AD-230 in Healthy Adults

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Apr 9, 2026
Registry last updated
Apr 13, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.